Avoidance of immune response prolongs expression of genes delivered to the adult rat myocardium by replication-defective adenovirus

Circulation

Volumn 94, Issue 6, 1996, Pages 1394-1401

  Quiñones, Manuel J ^a   Leor, Jonathan ^b   Kloner, Robert A ^a,b   Ito, Masamichi ^a   Patterson, Michael ^b   Witke, Werner F ^a   Kedes, Larry ^a,c  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b GOOD SAMARITAN HOSPITAL   (United States)

^c Institute for Genetic Medicine   (United States)

Author keywords

genes; immune system; myocardium; viruses

Indexed keywords

ADENOVIRUS; ADOLESCENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE TARGETING; HEART MUSCLE; IMMUNE RESPONSE; IMMUNOCOMPETENCE; MYOCARDITIS; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0029839669     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.94.6.1394     Document Type: Article

References (29)

1. Anderson WF. Human gene therapy. Science. 1992;256:808-813.
2. Miller AD. Human gene therapy comes of age. Nature. 1992; 357:455-460.
3. Prentice H, Kloner RA, Prigozy T, Christensen T, Newman L, Li Y, Kedes L. Tissue restricted gene expression assayed by direct DNA injection into cardiac and skeletal muscle. J Mol Cell Cardiol. 1994;26:1393-1401.
4. Nabel EG. Gene therapy for cardiovascular disease. Circulation. 1995;91:541-548.
5. Brody SL, Crystal RG. Adenovirus-mediated in vivo gene transfer. Ann NY Acad Sci. 1994;716:90-101.
6. Berker KL. Development of adenovirus vectors for the expression of heterologous genes. Biotechniques. 1988;6:616-629.
7. Zak R. Development and proliferative capacity of cardiac muscle cells. Circ Res. 1974;35(suppl V):V-17-V-28.
8. Stratford-Perricaudet LD, Makeh J, Perricaudet M, Briand P. Wide-spread long-term gene transfer to mouse skeletal muscles and heart. J Clin Invest. 1992;90:626-630.
9. Guzman RJ, Lemarchand P, Crystal RG, Epstein SE, Finkel T. Efficient gene transfer into myocardium by direct injection of adenovirus vectors. Circ Res. 1993;73:1202-1207.
10. Kass-Eisler A, Falck PE, Alvira M, Rivera J, Buttrick PM, Witten-berg BA, Cipriani L, Leinwand LA. Quantitative determination of adenovirus-mediated gene delivery to rat cardiac myocytes in vitro and in vivo. Proc Natl Acad Sci USA. 1993;90:11498-11502.
11. Barr E, Carroll J, Kalynych AM, Tripathy SK, Kozarsky K, Wilson JM, Leiden JM. Efficient catheter-mediated gene transfer into the heart using replication-defective adenovirus. Gene Ther. 1994;1:51-58.
12. French BA, Mazur W, Geske RS, Bolli R, Direct in vivo gene transfer into porcine myocardium using replication-deficient adenoviral vectors. Circulation. 1994;90:2414-2424.
13. Prince GA, Porter DD, Jenson AB, Horswood RL, Chanock RM, Ginsberg HS. Pathogenesis of adenovirus type-5 pneumonia in cotton rats (Sigmodon hispidus). J Virol. 1993;67:101-111.
14. Herz J, Gerard RD. Adeno virus-mediated transfer of low density lipoprotein receptor gene acutely accelerates cholesterol clearance in normal mice. Proc Natl Acad Sci USA. 1993;90:2812-2816.
15. Gomez FAM, Coats WS, Baque S, Alam T, Gerard RD, Newgard CB. Adenovirus-mediated transfer of the muscle glycogen phosphorylase gene into hepatocytes confers altered regulation of glycogen metabolism. J Biol Chem. 1992;267:25129-25134.
16. Juul P, Christensen HB, Hougen HP, Svendsen O, Thygesen P, Rygaard J. Athymic experimental animals in pharmaco-immunological research. Toxicol Lett. 1992;64/65:85-92.
17. Ginsberg HS, Moldawer LL, Sehgal PB, Redington M, Kilian PL, Chanock RM, Prince GA. A mouse model for investigating the molecular pathogenesis of adenovirus pneumonia. Proc Natl Acad Sci USA. 1991;88:1651-1655.
18. Yang Y, Nunes FA, Berencsi K, Furth EE, Gonczeol E, Wilson JM. Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc Natl Acad Sci USA. 1994;91:4407-4411.
19. Huber SA, Job LP, Woodruff JF. Lysis of infected myofibers by coxsackievirus B-3 immune T lymphocytes. Am J Pathol. 1980;98:681-694.
20. Huber SA, Lodge PA. Coxsackievirus B-3 myocarditis in Balb/c mice: evidence for autoimmunity to myocyte antigens. Am J Pathol. 1984;116:21-29.
21. Imperiale MJ, Kao H-T, Feldman LT, Nevins JR, Strickland S. Common control of the heat shock gene and early adenovirus genes: evidence for a cellular E1A-like activity. Mol Cell Biol. 1984; 4:867-874.
22. La Thangue NB, Rigby WJ. An adenovirus E1A-like transcription factor is regulated during the differentiation of murine embryonal carcinoma stem cells. Cell. 1987;49:507-513.
23. Dooley TP, Miranda M, Jones NC, DePamphilis ML. Transactivation of the adenovirus Ella promoter in the absence of adenovirus E1A protein is restricted to mouse oocytes and preimplantation embryos. Development. 1989;107:945-956.
24. Spergel JM, Chen-Kiang S. Interleukin 6 enhances a cellular activity that functionally substitutes for E1A protein in transactivation. Proc Natl Acad Sci USA. 1991;88:6472-6476.
25. Spergel JM, Hsu W, Akira S, Thimmappaya B. NF-IL6, a member of the C/EBP family, regulates El A-responsive promoters in the absence of E1A. J Virol. 1992;66:1021-1030.
26. Akira S, Isshiki H, Sugita T, Tanabe O, Kinoshita S, Nishio Y, Nakajima T, Hirano T, Kishimoto T. A nuclear factor for IL-6 expression (NF-IL6) is a member of a C/EBP family. EMBO J. 1990;9:1897-1906.
27. Yei S, Mittereder N, Tang K, O'Sullivan C, Trapnell BC. Adenovirus-mediated gene transfer for cystic fibrosis: quantitative evaluation of repeated in vivo vector administration to the lung. Gene Ther. 1994;1:192-200.
28. Lin H, Parmacek MS, Morle G, Boiling S, Leiden J. Expression of recombinant genes in myocardium in vivo after direct injection of DNA. Circulation. 1990;82:2217-2221.
29. Engelhardt JF, Ye X, Doranz B, Wilson JM. Ablation of E2A in recombinant adenoviruses improves transgene persistence and decreases inflammatory response in mouse liver. Proc Natl Acad Sci USA. 1994;91:6196-6200.